Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Oklahoma
Ohio State University Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic
Duke University
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center